Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Asset Utilization Ratio (2017 - 2026)

Organogenesis Holdings has reported Asset Utilization Ratio over the past 9 years, most recently at 1.02 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio changed 0.32% year-over-year to 1.02; the TTM value through Dec 2025 reached 1.02, changed 0.32%, while the annual FY2025 figure was 1.03, 2.23% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 1.02 at Organogenesis Holdings, up from 0.96 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 1.28 in Q2 2021 and troughed at 0.93 in Q2 2025.
  • A 5-year average of 1.04 and a median of 1.02 in 2023 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: tumbled 63.34% in 2021 and later grew 8.75% in 2024.
  • Year by year, Asset Utilization Ratio stood at 1.15 in 2021, then fell by 13.41% to 0.99 in 2022, then dropped by 5.61% to 0.94 in 2023, then rose by 8.75% to 1.02 in 2024, then fell by 0.32% to 1.02 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ORGO at 1.02 in Q4 2025, 0.96 in Q3 2025, and 0.93 in Q2 2025.